Lv65
2508 积分 2024-06-06 加入
[Recommendations on the diagnosis and treatment of osteoarthritis in China]
2天前
已完结
The obesity–inflammation axis in psoriatic disease: mechanisms and therapeutic strategies
16天前
已完结
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
19天前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
23天前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
23天前
已完结
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues?
23天前
已关闭
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues?
24天前
已关闭
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
24天前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
1个月前
已完结
皖公网安备34019202002308
